GeneCentric
PrivateLast Round
Series C
Jun 18, 2025
Total Funding Raised
$28.25M
Company Overview
GeneCentric is a precision oncology company that develops AI-driven diagnostic solutions and RNA-based gene expression signatures to identify patient populations likely to respond to specific cancer therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GeneCentric Comparables
Compare GeneCentric with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cofactor Genomics | 82% | |
| Exai Bio | 76% | |
| Labcorp | 74% | |
GeneCentric Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 18, 2025 | ||||
| Series B Extension | Nov 8, 2021 | ||||
| Series B | Sep 22, 2021 | ||||
| VC Round | Dec 22, 2016 | ||||
| Series A | Jul 22, 2014 | ||||
VC Round | Jul 8, 2013 |
Key People
Founding team and executive leadership
GeneCentric Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IAG Capital Partners | Series B Extension, Series B, Series C |
| Hatteras Venture Partners | Series A, Series B Extension, Series B, VC Round, Series C, Seed |
| Alexandria Venture Investments | Series B, Series C |
| Alexandria Venture Investments | Series B Extension, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 9, 2025
Launched PurIST, an RNA-based tumor classification test, with Tempus.
- Sep 9, 2025
Collaborated with Tempus to develop and deploy PurIST RNA-based algorithm test.
GeneCentric Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GeneCentric's valuation, stock price, and market status.